Modelling heterogeneity in patients' preferences for the attributes of a general practitioner appointment

Journal of Health Economics
Arne Risa Hole

Abstract

This paper examines the distribution of preferences among respondents to a discrete choice experiment on the choice of general practitioner appointments. In addition to standard logit, mixed and latent class logit models are used to analyse the data from the choice experiment. It is found that there is significant preference heterogeneity for all the attributes in the experiment and that both the mixed and latent class models lead to significant improvements in fit compared to the standard logit model. Moreover, the distribution of preferences implied by the preferred mixed and latent class models is similar for many attributes.

References

Dec 17, 2002·Health Economics·Nick HanleyRobert Wright
Apr 20, 2004·Accident; Analysis and Prevention·Paula Iragüen, Juan de Dios Ortúzar
Oct 26, 2005·Journal of Health Economics·Jane HallJordan J Louviere
Mar 7, 2006·Health Economics·Teresa Bago d'Uva
Jan 24, 2007·Health Economics·Madeleine T KingChristine R Jenkins

❮ Previous
Next ❯

Citations

Jun 28, 2011·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Joachim Marti
Jun 22, 2012·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Maurus Rischatsch, Peter Zweifel
Feb 27, 2009·International Journal of Health Care Finance and Economics·Lieke H H M BoonenXander Koolman
Nov 6, 2012·International Journal of Health Care Finance and Economics·Andrew J Epstein, Scott J Johnson
Oct 19, 2013·Journal of Health Economics·Geir Godager, Daniel Wiesen
Sep 1, 2009·Health Economics, Policy, and Law·Jordan J Louviere, Emily Lancsar
Jan 22, 2014·PharmacoEconomics·Aleksandra TorbicaFabio Ayala
Jun 21, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Line Bjørnskov Pedersen, Dorte Gyrd-Hansen
Jul 10, 2014·PharmacoEconomics·Michael D ClarkEsther W de Bekker-Grob
Nov 19, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Chiara SeghieriSabina Nuti
May 12, 2010·Bulletin of the World Health Organization·Margaret E KrukMawuli Dzodzomenyo
Jan 8, 2015·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Patricia KennyStephen Goodall
Sep 4, 2012·Journal of Health Economics·Peter SiveyJohn Humphreys
Aug 17, 2014·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Lucas M A GoossensMaureen P M H Rutten-van Mölken
Mar 19, 2014·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Marjon van der PolMandy Ryan
Jul 6, 2010·Journal of Health Economics·Andrew J Epstein
Nov 3, 2009·Social Science & Medicine·F Reed JohnsonKathryn A Phillips
Aug 2, 2015·PharmacoEconomics·Liesbet van de WeteringWerner B F Brouwer
Apr 27, 2011·Health Services Research·Margaret E KrukRose Macauley
Oct 30, 2010·Health Services Research·Lieke H H M BoonenFrederik T Schut
Aug 10, 2011·Health Economics·Denzil G FiebigDeborah J Street
Jan 11, 2013·The International Journal of Pharmacy Practice·Pradnya Naik-PanvelkarBandana Saini
Jun 28, 2014·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Mirja Elisabeth KløjgaardRikke Søgaard
Nov 12, 2014·Health Economics Review·Richard A Iles, John M Rose
Feb 27, 2015·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Rosalba RosatoAntonio Bertolotto
Jul 3, 2015·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Christian Pfarr, Andreas Schmid
Apr 22, 2014·The International Journal on Drug Policy·Marian ShanahanAlison Ritter
Aug 8, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Karen GerardAlesha Smith
Aug 8, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Tim M BenningBenedict G C Dellaert
Jan 8, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Katherine PayneWilliam G Newman
May 16, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Line Bjørnskov PedersenDorte Gyrd-Hansen
Sep 15, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Na GuoFawziah Marra
Oct 13, 2014·Social Science & Medicine·Jinhu LiJulia Witt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.